Skip to main navigation

News
Investors
Careers
Contact

About Us
Our Approach
- What We Do
- Partnering
Patients & Providers
Products
Science & Pipeline
Investors
Careers
- Culture
- Job Openings
Contact
Home
Menu Menu

Event Details

Overview
Events & Presentations
Stock Information
Press Releases
Corporate Governance
State Compliance
SEC Filings
- Quarterly Results
Contact
Email Alerts
FAQs

U.S. FDA Approval as Treatment for Niemann-Pick Disease Type C

09-23-2024 8:00 AM EDT

Listen to webcast

About Us
Our Approach
- What We Do
- Partnering
Patients & Providers
Products
Science & Pipeline
Investors
Careers
- Culture
- Job Openings
Contact
Home

© 2024 Zevra Therapeutics, Inc. All rights reserved. Privacy Policy | Terms of Use